Singapore markets close in 7 hours 22 minutes

Straits Times Index
3,308.09
+4.43(+0.13%)
Nikkei
38,227.58
+48.12(+0.13%)
Hang Seng
19,203.82
+88.76(+0.46%)
FTSE 100
8,414.99
-18.77(-0.22%)
Bitcoin USD
62,964.50
+1,617.93(+2.64%)
CMC Crypto 200
1,295.20
+35.00(+2.78%)

Theravance Biopharma Inc (0TB.BE)

Berlin - Berlin Delayed price. Currency in EUR

Add to watchlist

8.70

+0.05

(+0.58%)

At close: 08:21PM CEST

Loading interactive chart…

Zacks
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
Theravance Bio (TBPH) delivered earnings and revenue surprises of 52.63% and 0.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PR Newswire
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced financial and operational results for the first quarter of 2024.
PR Newswire
Theravance Biopharma to Participate in an Upcoming Investor Conference
Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ Monday, May 20 at 11:30 AM EDT (8:30 AM PDT / 4:30 PM IST) and will be hosting in-person meetings with the investment community at the conference.